CoChat

Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukaemia

Open access
Talbot, S, Nelson, R, Self, W T · 2008 · British Journal of Pharmacology
Cited by 64

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Background and purpose: Arsenicals have been used medicinally for decades to treat both infectious disease and cancer. Arsenic trioxide (As 2 O 3) is effective for treatment of acute promyelocytic leukaemia (APL), yet the mechanism of action of this drug is still widely debated. Recently, As 2 O 3 was shown to inhibit the activity of the selenoenzyme thioredoxin reductase (TrxR). TrxR has been proposed to be required for selenium metabolism. The effect of inhibitors of TrxR on selenium metabolism has yet to be assessed. This study aims to determine whether chemotherapeutics that target selenocysteine within selenoenzymes may also affect the metabolism of selenium. Experimental approach: A lung cell line, A549, was used to assess the effect of TrxR inhibitors on selenium metabolism, using 75 Se‐selenite. The level of mRNA encoding cytosolic TrxR (TrxR1) was determined using real‐time reverse transcriptase‐PCR. TrxR activity was determined in whole‐cell extracts. Key results: Exposure of cells to As 2 O 3, arsenite or auranofin led to a concentration‐dependent reduction of selenium metabolism into selenoproteins. Knockdown of TrxR1, using small inhibitory RNA, did not affect selenium metabolism. Exposure of cells to monomethylarsonic acid, a potent inhibitor of TrxR, did not alter selenium metabolism but did inhibit enzyme activity. Conclusions and implications: As 2 O 3 and auranofin block the metabolism of selenium in A549 cells. Because As 2 O 3 is used to treat APL, our findings may reveal the mechanism of this therapeutic action and lead to further research targeting selenium metabolism to find novel chemotherapeutic agents for the treatment of APL. British Journal of Pharmacology (2008) 154, 940–948; doi:10.1038/bjp.2008.161; published online 21 April 2008

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/bjp.2008.161

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Arsenite Causes DNA Damage in Keratinocytes Via Generation of Hydroxyl Radicals

    Shi, H., Hudson, L. G., Ding, W., Wang, S., Cooper, K. L., Liu, S., Chen, Y., Shi, X., & Liu, K. J. (2004) · Chemical Research in Toxicology · doi:10.1021/tx049939e · Cited by 159 · cited 2×

    “Hydrogen peroxide has been implicated as the primary oxidant that increases upon exposure to arsenite (Pi et al., 2003); however, there is also evidence that superoxide and hydroxyl radicals increase (Shi et al., 2004).”
    Background

Cited by

See all 64

Metadata

Authors
Talbot, S., Nelson, R., & Self, W. T.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2008-07
Volume
154
Issue
5
Pages
940-948
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2030421521
Cited by
64
References
1
FWCI
5.92
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.